Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy
Clinical trial NCT03039686 · COMPLETED
Trial details
- NCT number
- NCT03039686
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-06
- Primary completion
- 2020-04-28
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.